Browsing: chief

BioCryst Pharmaceuticals has appointed David W. Jenkins, Ph.D., as its first chief scientific officer, a newly created executive role designed to strengthen the company’s research strategy as it expands its rare disease pipeline through external innovation and partnerships. The appointment is effective immediately, with Jenkins reporting to Chief Research and Development Officer Dr. Sandeep Menon…

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk